Cargando…

Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer

BACKGROUND: For recurrent laryngeal cancer, the feasibility of salvage transoral laser microsurgery (TLM) remains controversial. This study compared the efficacy of TLM and open partial laryngectomy (OPL) for treatment of early local recurrence of glottic squamous cell cancer (GSCC) and confirm the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Zhimou, Yue, Huijun, Chen, Lin, Xv, Yang, Li, Yun, Tang, Bingjie, Lin, Yu, Lei, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228086/
https://www.ncbi.nlm.nih.gov/pubmed/37248502
http://dx.doi.org/10.1186/s40463-023-00628-7
_version_ 1785050897314742272
author Cai, Zhimou
Yue, Huijun
Chen, Lin
Xv, Yang
Li, Yun
Tang, Bingjie
Lin, Yu
Lei, Wenbin
author_facet Cai, Zhimou
Yue, Huijun
Chen, Lin
Xv, Yang
Li, Yun
Tang, Bingjie
Lin, Yu
Lei, Wenbin
author_sort Cai, Zhimou
collection PubMed
description BACKGROUND: For recurrent laryngeal cancer, the feasibility of salvage transoral laser microsurgery (TLM) remains controversial. This study compared the efficacy of TLM and open partial laryngectomy (OPL) for treatment of early local recurrence of glottic squamous cell cancer (GSCC) and confirm the effectiveness of salvage TLM as a treatment option. METHODS: This retrospective study involved 55 patients with early local recurrent GSCC treated with TLM, and the oncologic outcomes, functional outcomes, hospitalization time and complications were compared with a group of 40 recurrent GSCC patients matched for clinical variables of TLM group, treated by OPL by the same team of surgeons. RESULTS: The 5-year overall survival and disease-specific survival rates were 65.8% and 91.5%, respectively, for 55 patients with rT(is)–rT(2) stage treated by TLM and 77.1% and 94.7%, respectively, for 40 patients with rT(is)–rT(2) stage treated by OPL (OPL group). In the TLM and OPL groups, the local control rates after 5 years were 77.5% and 79.3%, respectively, and the laryngeal preservation rates were 94.4% and 83.6%, respectively (p > 0.05). Compared with the OPL group, the complication rate (1.82%) and hospitalization duration (5.42 ± 2.26 days) were significantly lower in the TLM group (p < 0.05). Compared with the OPL group, postsurgical health-related quality of life and quality of voice were significantly better in the TLM group (p < 0.001). CONCLUSION: Salvage TLM can be used as an effective treatment option for suitable patients after a full, comprehensive, and careful assessment of the characteristics of early locally recurrent glottic carcinoma. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40463-023-00628-7.
format Online
Article
Text
id pubmed-10228086
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102280862023-05-31 Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer Cai, Zhimou Yue, Huijun Chen, Lin Xv, Yang Li, Yun Tang, Bingjie Lin, Yu Lei, Wenbin J Otolaryngol Head Neck Surg Original Research Article BACKGROUND: For recurrent laryngeal cancer, the feasibility of salvage transoral laser microsurgery (TLM) remains controversial. This study compared the efficacy of TLM and open partial laryngectomy (OPL) for treatment of early local recurrence of glottic squamous cell cancer (GSCC) and confirm the effectiveness of salvage TLM as a treatment option. METHODS: This retrospective study involved 55 patients with early local recurrent GSCC treated with TLM, and the oncologic outcomes, functional outcomes, hospitalization time and complications were compared with a group of 40 recurrent GSCC patients matched for clinical variables of TLM group, treated by OPL by the same team of surgeons. RESULTS: The 5-year overall survival and disease-specific survival rates were 65.8% and 91.5%, respectively, for 55 patients with rT(is)–rT(2) stage treated by TLM and 77.1% and 94.7%, respectively, for 40 patients with rT(is)–rT(2) stage treated by OPL (OPL group). In the TLM and OPL groups, the local control rates after 5 years were 77.5% and 79.3%, respectively, and the laryngeal preservation rates were 94.4% and 83.6%, respectively (p > 0.05). Compared with the OPL group, the complication rate (1.82%) and hospitalization duration (5.42 ± 2.26 days) were significantly lower in the TLM group (p < 0.05). Compared with the OPL group, postsurgical health-related quality of life and quality of voice were significantly better in the TLM group (p < 0.001). CONCLUSION: Salvage TLM can be used as an effective treatment option for suitable patients after a full, comprehensive, and careful assessment of the characteristics of early locally recurrent glottic carcinoma. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40463-023-00628-7. BioMed Central 2023-05-29 /pmc/articles/PMC10228086/ /pubmed/37248502 http://dx.doi.org/10.1186/s40463-023-00628-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Research Article
Cai, Zhimou
Yue, Huijun
Chen, Lin
Xv, Yang
Li, Yun
Tang, Bingjie
Lin, Yu
Lei, Wenbin
Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
title Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
title_full Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
title_fullStr Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
title_full_unstemmed Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
title_short Salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
title_sort salvage transoral laser microsurgery for early local recurrence of glottic squamous cell cancer
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228086/
https://www.ncbi.nlm.nih.gov/pubmed/37248502
http://dx.doi.org/10.1186/s40463-023-00628-7
work_keys_str_mv AT caizhimou salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT yuehuijun salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT chenlin salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT xvyang salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT liyun salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT tangbingjie salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT linyu salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer
AT leiwenbin salvagetransorallasermicrosurgeryforearlylocalrecurrenceofglotticsquamouscellcancer